Intuitive Surgical (NASDAQ:ISRG) Upgraded at Oppenheimer

Oppenheimer upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a market perform rating to an outperform rating in a research note released on Wednesday morning, MarketBeat.com reports. The firm currently has $500.00 target price on the medical equipment provider’s stock.

ISRG has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft decreased their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Mizuho set a $500.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Finally, The Goldman Sachs Group set a $558.00 target price on Intuitive Surgical in a research note on Wednesday, May 27th. Twenty-two analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

Intuitive Surgical Stock Performance

ISRG stock opened at $394.51 on Wednesday. The company has a market cap of $139.37 billion, a price-to-earnings ratio of 45.19, a P/E/G ratio of 2.90 and a beta of 1.46. Intuitive Surgical has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The business’s 50-day moving average is $391.45 and its two-hundred day moving average is $441.28.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the firm posted $1.81 EPS. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. Equities analysts predict that Intuitive Surgical will post 8.87 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the director owned 251 shares of the company’s stock, valued at $95,129. This trade represents a 61.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares in the company, valued at $498,271,600. The trade was a 0.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 17,106 shares of company stock valued at $6,949,518. Insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Ancora Advisors LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at $970,000. Jones Financial Companies Lllp acquired a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $236,000. Manning & Napier Advisors LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth $89,000. Dearborn Partners LLC purchased a new position in Intuitive Surgical in the second quarter valued at about $312,000. Finally, Ally Financial Inc. acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $3,977,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.